Article Details
Retrieved on: 2024-08-27 20:10:20
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the delay by the DEA in rescheduling cannabis, emphasizing the disappointment among industry leaders who anticipated regulatory clarity. This delay affects the cannabis industry's legal and financial aspects, directly linking to the key concept of 'Medical cannabis' and tags like 'Cannabis law' and 'Removal of cannabis from Schedule I of the Controlled Substances Act.'
Article found on: www.forbes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here